Literature DB >> 25065745

Profound and rapid reduction in body temperature induced by the melanocortin receptor agonists.

Yuanzhong Xu1, Eun Ran Kim1, Shengjie Fan2, Yan Xia3, Yong Xu3, Cheng Huang4, Qingchun Tong5.   

Abstract

The melanocortin receptor 4 (MC4R) plays a major role in body weight regulation and its agonist MTII has been widely used to study the role of MC4Rs in energy expenditure promotion and feeding reduction. Unexpectedly, we observed that intraperitoneal (i.p.) administration of MTII induced a rapid reduction in both body temperature and energy expenditure, which was independent of its effect on feeding and followed by a prolonged increase in energy expenditure. The rapid reduction was at least partly mediated by brain neurons since intracerebroventricular (icv) administration of alpha melanocyte-stimulating hormone, an endogenous melanocortin receptor agonist, produced a similar response. In addition, the body temperature-lowering effect of MTII was independent of the presence of MC4Rs, but in a similar fashion to the previously shown effect on body temperature by 5'AMP. Moreover, β-adrenergic receptors (β-ARs) were required for the recovery from low body temperature induced by MTII and further pharmacological studies showed that the MTII's effect on body temperature may be partially mediated by the vasopressin V1a receptors. Collectively, our results reveal a previously unappreciated role for the melanocortin pathway in rapidly lowering body temperature.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-MSH; Body temperature; Energy expenditure; Feeding; MTII; Melanocortin

Mesh:

Substances:

Year:  2014        PMID: 25065745      PMCID: PMC4162093          DOI: 10.1016/j.bbrc.2014.07.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis.

Authors:  Joel K Elmquist; Roberto Coppari; Nina Balthasar; Masumi Ichinose; Bradford B Lowell
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

Review 2.  Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

Authors:  Mac E Hadley; Robert T Dorr
Journal:  Peptides       Date:  2006-01-18       Impact factor: 3.750

3.  Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone.

Authors:  M T Murphy; D B Richards; J M Lipton
Journal:  Science       Date:  1983-07-08       Impact factor: 47.728

4.  Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat.

Authors:  Domenico Tupone; Christopher J Madden; Shaun F Morrison
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

5.  Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition.

Authors:  Russell S Ray; Andrea E Corcoran; Rachael D Brust; Jun Chul Kim; George B Richerson; Eugene Nattie; Susan M Dymecki
Journal:  Science       Date:  2011-07-29       Impact factor: 47.728

6.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.

Authors:  W Fan; B A Boston; R A Kesterson; V J Hruby; R D Cone
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

7.  betaAR signaling required for diet-induced thermogenesis and obesity resistance.

Authors:  Eric S Bachman; Harveen Dhillon; Chen-Yu Zhang; Saverio Cinti; Antonio C Bianco; Brian K Kobilka; Bradford B Lowell
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

8.  Glutamate release mediates leptin action on energy expenditure.

Authors:  Yuanzhong Xu; Eun Ran Kim; Rongjie Zhao; Martin G Myers; Heike Munzberg; Qingchun Tong
Journal:  Mol Metab       Date:  2013-01-29       Impact factor: 7.422

9.  Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins.

Authors:  Karolina P Skibicka; Harvey J Grill
Journal:  Endocrinology       Date:  2009-10-23       Impact factor: 4.736

10.  Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat.

Authors:  Maria M Glavas; Sandra E Joachim; Shin J Draper; M Susan Smith; Kevin L Grove
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

View more
  5 in total

1.  Melanotan II causes hypothermia in mice by activation of mast cells and stimulation of histamine 1 receptors.

Authors:  Shalini Jain; Anna Panyutin; Naili Liu; Cuiying Xiao; Ramón A Piñol; Priyanka Pundir; Clémence Girardet; Andrew A Butler; Xinzhong Dong; Oksana Gavrilova; Marc L Reitman
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-05-29       Impact factor: 4.310

2.  Hypothalamic Non-AgRP, Non-POMC GABAergic Neurons Are Required for Postweaning Feeding and NPY Hyperphagia.

Authors:  Eun Ran Kim; Zhaofei Wu; Hao Sun; Yuanzhong Xu; Leandra R Mangieri; Yong Xu; Qingchun Tong
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

Review 3.  The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances.

Authors:  Jennifer W Hill; Latrice D Faulkner
Journal:  Neuroendocrinology       Date:  2016-10-11       Impact factor: 4.914

4.  Red blood cell β-adrenergic receptors contribute to diet-induced energy expenditure by increasing O2 supply.

Authors:  Eun Ran Kim; Shengjie Fan; Dmitry Akhmedov; Kaiqi Sun; Hoyong Lim; William O'Brien; Yuanzhong Xu; Leandra R Mangieri; Yaming Zhu; Cheng-Chi Lee; Yeonseok Chung; Yang Xia; Yong Xu; Feng Li; Kai Sun; Rebecca Berdeaux; Qingchun Tong
Journal:  JCI Insight       Date:  2017-07-20

Review 5.  Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.

Authors:  Fabio Rotondo; Henriett Butz; Luis V Syro; George M Yousef; Antonio Di Ieva; Lina M Restrepo; Andres Quintanar-Stephano; Istvan Berczi; Kalman Kovacs
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.